Alethia Young is of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 13,067 shares of PTCT, which is worth approximately $680,398. The most recent transaction as insider was on Feb 15, 2024, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.1K
0% 3M change
44.12% 12M change
Total Value Held $680,398

Alethia Young Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2024
BUY
Grant, award, or other acquisition
-
4,000 Added 23.44%
13,067 Common Stock
Sep 06 2023
SELL
Open market or private sale
$464,890 $39.85 p/Share
11,666 Reduced 56.27%
9,067 Common Stock
Sep 06 2023
BUY
Exercise of conversion of derivative security
$324,898 $27.85 p/Share
11,666 Added 45.93%
13,733 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
4,000 Added 30.61%
9,067 Common Stock
Jun 09 2022
BUY
Grant, award, or other acquisition
-
5,067 Added 50.0%
5,067 Common Stock

Also insider at

GRPH
Graphite Bio, Inc. Healthcare
BCYC
BICYCLE THERAPEUTICS plc Healthcare
PCRX
Pacira BioSciences, Inc. Healthcare
AY

Alethia Young

South Plainfield, NJ

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT